Andrew Hill Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.56M | Buy |
8,003
+1,430
| +22% | +$637K | 2.87% | 17 |
|
|
2025
Q1 | $3.19M | Buy |
6,573
+19
| +0.3% | +$9.21K | 3.08% | 14 |
|
|
2024
Q4 | $2.64M | Sell |
6,554
-2,335
| -26% | -$940K | 1.96% | 22 |
|
|
2024
Q3 | $4.13M | Sell |
8,889
-65
| -0.7% | -$30.2K | 3.1% | 14 |
|
|
2024
Q2 | $4.2M | Buy |
8,954
+32
| +0.4% | +$15K | 3.48% | 10 |
|
|
2024
Q1 | $3.73M | Sell |
8,922
-3,340
| -27% | -$1.4M | 3.29% | 8 |
|
|
2023
Q4 | $4.99M | Buy |
+12,262
| New | +$4.99M | 5.2% | 2 |
|
|
2022
Q3 | $4.38M | Buy |
+15,138
| New | +$4.38M | 5.95% | 4 |
|